The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Saxe Jon S since year 2005.
The trader's CIK number is 1114914.
At the time of this reporting, Saxe Jon S is the Director of First Horizon Pharmaceutical Corp .
(stock ticker symbol FHRX).
See this page for all insider trading activities at First Horizon Pharmaceutical Corp .
Note that in the past SAXE JON S also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Saxe Jon S since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2008-05-23
SCRX
First Horizon Pharmaceutical Corp
Option Exercise
3,750
.00
0
2008-05-23
SCRX
First Horizon Pharmaceutical Corp
Sale
3,750
21.08
79,050
2008-04-09
PDLI
Protein Design Labs Inc/de
Option Exercise
120,000
4.25
510,000
2008-03-28
PDLI
Protein Design Labs Inc/de
Option Exercise
93,200
9.66
899,957
2008-03-06
PDLI
Protein Design Labs Inc/de
Option Exercise
20,600
9.66
198,917
2008-03-03
PDLI
Protein Design Labs Inc/de
Option Exercise
35,360
9.66
341,443
2008-02-27
PDLI
Protein Design Labs Inc/de
Option Exercise
10,840
9.66
104,673
2007-11-20
SCLN
Sciclone Pharmaceuticals Inc
Purchase
10,000
1.89
18,900
2007-11-21
SCLN
Sciclone Pharmaceuticals Inc
Purchase
5,000
1.89
9,433
2007-09-13
ISV
Insite Vision Inc
Purchase
15,000
1.09
16,350
2006-11-06
PDLI
Protein Design Labs Inc/de
Option Exercise
40,000
6.62
265,000
2006-10-31
SCRX
First Horizon Pharmaceutical Corp
Option Exercise
15,000
.00
0
2006-10-31
SCRX
First Horizon Pharmaceutical Corp
Sale
7,500
21.83
163,727
2006-07-19
PDLI
Protein Design Labs Inc/de
Option Exercise
30,000
6.62
198,750
2006-07-19
PDLI
Protein Design Labs Inc/de
Option Exercise
30,000
6.62
198,750
2006-05-30
PDLI
Protein Design Labs Inc/de
Option Exercise
30,000
6.62
198,750
2006-04-18
PDLI
Protein Design Labs Inc/de
Sale
5,000
30.01
150,046
2006-04-10
PDLI
Protein Design Labs Inc/de
Sale
5,000
30.58
152,912
2006-04-03
PDLI
Protein Design Labs Inc/de
Sale
10,000
32.78
327,798
2006-03-29
PDLI
Protein Design Labs Inc/de
Sale
5,000
32.00
160,025
2006-03-27
PDLI
Protein Design Labs Inc/de
Sale
5,000
31.25
156,244
2006-03-20
PDLI
Protein Design Labs Inc/de
Sale
10,000
32.24
322,363
2006-03-13
PDLI
Protein Design Labs Inc/de
Sale
10,000
31.72
317,229
2006-03-08
PDLI
Protein Design Labs Inc/de
Sale
5,000
32.12
160,620
2006-03-06
PDLI
Protein Design Labs Inc/de
Sale
5,000
31.37
156,834
2006-03-03
PDLI
Protein Design Labs Inc/de
Sale
5,000
32.00
160,000
2006-02-27
PDLI
Protein Design Labs Inc/de
Sale
5,000
30.71
153,530
2006-02-24
PDLI
Protein Design Labs Inc/de
Sale
5,000
30.00
150,000
2006-01-09
PDLI
Protein Design Labs Inc/de
Sale
6,000
30.88
185,286
2006-01-05
PDLI
Protein Design Labs Inc/de
Sale
5,000
30.00
150,000
2006-01-04
PDLI
Protein Design Labs Inc/de
Sale
5,000
30.03
150,150
2005-12-23
PDLI
Protein Design Labs Inc/de
Sale
10,000
30.00
300,000
2005-10-04
PDLI
Protein Design Labs Inc/de
Sale
5,000
30.27
151,350
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Saxe Jon S
(Director of First Horizon Pharmaceutical Corp at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
